Evaluating the potential for immune escape: how likely is an antibody to protect against a specific SARS-CoV-2 variant?
10 Jun 2022 | Teaching Materials | Contributor(s):
By Sandra Porter1, Uwe Hilgert2, Erica Lannan3, Michelle Stieber4
1. Digital World Biology 2. Bio5 Institute 3. Prairie State College 4. Cerritos College
Commercial antibodies to the SARS-CoV-2 spike protein have been successfully used to treat people with COVID-19. Unfortunately, as the SARS-CoV-2 virus evolves, new variants have appeared that can...
https://qubeshub.org/publications/2913/?v=1